Conversations on Cancer: National Hispanic Family Cancer Awareness Week
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Yousef Zakharia, MD, discusses the evolving use of checkpoint inhibitors and emerging triplet regimens in clear cell renal cell carcinoma.
Various kidney cancer trials have combined agents such as A2a receptor inhibitors with immunotherapy backbones to potentially improve treatment outcomes.
Nature Cancer – Swanton and colleagues present a clonal expression signature, ORACLE, which, in combination with clinicopathological and molecular risk factors, can predict survival of…
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
Uncover the future of lymphoma care with Marc Hoffman, Professor, Hematologic Malignancies at the University of Kansas Medical Center.
Here is your snapshot of all therapeutic options greenlit by the FDA in December 2024 spanning tumor types.
Registration is now open
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Obesity at cancer diagnosis was independently associated with inferior outcome in children and adolescents with cancer, particularly in patients with acute lymphoblastic leukemia and central…
A Mayo Clinic “lifer” who did not consider medicine as a career path until his later teenage years grew into a powerhouse who touched nearly…